
Biosimilars: In Biologic Medicines
|
Please take survey below
The Global Colon Cancer Association is conducting a brief survey on biosimilars among the global patient and caregiver community.
You do not need to be a colorectal cancer patient to take this survey. We are seeking input from individuals who are patients being treated for all disease types as well as caregivers.
If biologic medicines is a topic that you do not know a lot about, you are not alone! And we still want to hear from you!
Note: In this survey, we refer to your country’s regulatory agency. A regulatory agency oversees the approval and monitors the safety of many products including drugs and medical devices.
Here are a few examples of the names of the regulatory agencies in various countries:
Note: In this survey, we refer to your country’s regulatory agency. A regulatory agency oversees the approval and monitors the safety of many products including drugs and medical devices.
Here are a few examples of the names of the regulatory agencies in various countries:
Brazil: National Heath Surveillance Agency (ANVISA)
Canada: HealthCanada’s Health Products and Food Branch (HPFB)
India: The Central Drugs Standard Control Organization (CDSCO)
India: The Central Drugs Standard Control Organization (CDSCO)
Europe: European Medicines Agency (EMA)
Nigeria: National Agency for Food and Drug Administration and Control (NAFDAC)
US: The U.S. Food and Drug Administration’s (FDA)
Vietnam: Drug Administration of Vietnam (DAV)
If you have any questions, please contact us at info@globalcca.org.
Thank you!
SURVEY QUESTIONS: